Skip to main content
    I

    InnovAge Holding Corp (INNV)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $8.97
    -0.12 (-1.32%)

    Market Cap: $1.24B

    Last updated: Nov 06, 2026 at 4:10 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    48%(13/27)
    Avg Surprise
    +7.17%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$0.09
    Range$0.09 - $0.09
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.090.0%
    60d ago$0.090.0%
    30d ago$0.00n/a
    7d ago$0.10-10.0%
    Current$0.09
    Revenue Consensus
    $261M
    Range$260M - $262M
    2 analysts
    Last 12 of 40 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$0.09$0.09 - $0.09--1
    No revisions (30d)
    		-
    Sep 26
    Reported Nov 3
    		$0.14$0.11$0.11 - $0.11+27.27%Beat1
    No revisions (30d)
    		+100.0%
    Jun 26
    Reported Sep 8
    		$0.06$0.09$0.09 - $0.09-33.33%Miss1
    1
    0
    30d
    		+700.0%
    Mar 26
    Reported May 5
    		$0.17$0.05$0.05 - $0.05+240.00%Beat1
    No revisions (30d)
    		+750.0%
    Dec 25
    Reported Feb 3
    		$0.10$0.04$0.04 - $0.04+150.00%Beat1
    No revisions (30d)
    		+1100.0%
    Sep 25
    Reported Nov 4
    		$0.07$0.04$0.04 - $0.04+75.00%Beat1
    No revisions (30d)
    		+450.0%
    Jun 25
    Reported Sep 9
    		$-0.01$-0.01$-0.01 - $-0.01+24.81%Beat1
    No revisions (30d)
    		+0.0%
    Mar 25
    Reported May 6
    		$0.02$-0.01$-0.01 - $-0.01+300.00%Beat1
    No revisions (30d)
    		+150.0%
    Dec 24
    Reported Feb 4
    		$-0.01$-0.01$-0.01 - $-0.01+13.04%Beat0
    No revisions (30d)
    		-200.0%
    Sep 24
    Reported Nov 5
    		$-0.02$-0.01$-0.01 - $0.00-100.00%Miss4
    No revisions (30d)
    		+75.0%
    Jun 24
    Reported Sep 10
    		$-0.01N/A-+66.67%Beat3
    No revisions (30d)
    		+88.9%
    Mar 24
    Reported May 7
    		$-0.04$-0.03$-0.04 - $-0.03-33.33%Miss4
    No revisions (30d)
    		+20.0%
    Dec 23
    Reported Feb 6
    		$0.01$-0.02-+150.00%Beat4
    No revisions (30d)
    		+114.3%

    Key Metrics

    Valuation
    P/E Ratio19.09EV/EBITDA30.52x
    Price/FCF16.03xFCF Yield6.24%
    Profitability
    Profit Margin0.88%Operating Margin7.61%
    ROE4.43%ROIC5.01%
    Financial Health
    Debt/Equity0.21xInterest CoverageN/A
    Current Ratio1.16xQuick Ratio1.16x
    Trading Statistics
    Beta0.19Avg Volume613.39K
    52-Week High$12.6452-Week Low$4.65

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$9.15
    SMA 20$9.14
    SMA 50$9.65
    SMA 200$9.15
    EMA 10$9.15
    EMA 20$9.20
    EMA 50$9.53
    EMA 200$8.87

    MACD

    Line: -0.10Signal: -0.14Hist: 0.04

    ADX

    ADX: 13.6+DI: 19.0-DI: 18.5

    Aroon & PSAR

    Aroon Up96.0
    Aroon DownN/A
    PSAR$8.85

    Bollinger Bands

    Upper Band$9.63
    Lower Band$8.66
    %B Position1065%(Upper)
    Band Width0.32

    RSI (14-Day)

    Neutral
    44.8

    Momentum Oscillators

    Stoch %K45.1
    Stoch %D41.6
    Williams %R-83.2
    ROC (10d)-6.1%
    Momentum-0.58
    CCI (20d)-55.4
    MFI (14d)57.3

    Volatility Measures

    ATR (14d)$0.46(5.1%)
    StdDev (20d)0.24
    Hist Vol54.2%(High)

    Volume Flow

    VWAP$9.04
    OBV2.2M
    AD Line-292.8K
    CMF (20d)-0.055

    Volume Metrics

    Avg Vol (20d)598.3K
    Vol Ratio1.3x
    VWMA (20d)$9.19

    Pivot Points

    R3$10.59
    R2$10.25
    R1$9.67
    Pivot Point$9.33
    S1$8.75
    S2$8.41
    S3$7.83

    Advanced Oscillators

    TSI-8.66
    Ultimate Osc41.0
    KST-35.64

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$264.76M$261.95M$251.94M$239.71M$236.10M$221.42M$218.14M$209.00M$205.14M$199.40M$193.07M$188.90M
    Cost of Revenue$85.50M$83.65M$77.68M$74.88M$75.89M$71.96M$69.50M$64.06M$63.39M$60.13M$59.08M$54.32M
    Gross Profit$179.26M$178.30M$174.27M$164.82M$160.22M$149.46M$148.64M$144.94M$141.75M$139.27M$133.99M$134.58M
    Operating Expenses$159.11M$168.15M$203.35M$151.56M$151.93M$151.61M$158.80M$157.49M$146.65M$144.15M$139.79M$136.36M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$29.15M$33.08M$76.53M$26.61M$30.27M$27.82M$38.60M$28.10M$27.54M$29.59M$27.55M$25.25M
    Operating Income$20.15M$10.15M$-29,079,000$13.26M$8.29M$-2,151,000$-10,158,000$-12,556,000$-4,896,000$-4,884,000$-5,793,000$-1,785,000
    Interest Income$-123,000$-773,000$-988,000$-1,246,000$-1,251,000$-2,858,000$-1,160,000$-744,000$-1,243,000$3.44M$-1,140,000$-2,817,000
    Interest Expense$113,000$479,000$694,000$806,000$373,000$2.05M$903,000$901,000$410,000$0$615,000$1.94M
    Income Before Tax$20.04M$9.67M$-29,773,000$12.46M$7.92M$-4,203,000$-11,061,000$-13,457,000$-5,306,000$-947,000$-6,408,000$-3,728,000
    Income Tax Expense$-841,000$-116,000$167,000$651,000$247,000$806,000$72,000$34,000$404,000$1.31M$-224,000$93,000
    Net Income$20.88M$9.78M$-29,940,000$11.80M$7.67M$-5,009,000$-11,133,000$-13,491,000$-5,710,000$-2,254,000$-6,184,000$-3,821,000
    EBITDA$26.00M$17.04M$-23,834,000$18.77M$14.46M$2.16M$-4,408,000$-7,285,000$1.45M$1.05M$-99,000$3.49M
    EBIT$20.16M$10.44M$-28,785,000$13.70M$9.17M$-1,345,000$-9,901,000$-12,713,000$-4,063,000$-4,384,000$-5,268,000$-911,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about INNV

    News

    After public-offering share sales, TCO reports its remaining stake in InnovAge (INNV).

    TCO Group Holdings, L.P. has reported an amended passive investment disclosure for InnovAge Holding Corp. (INNV), indicating a 74.08% beneficial ownership stake. This percentage reflects 101,076,555 common shares...

    Stock Titan•11/5/26•Neutral

    InnovAge Holding Corp. (INNV) Seasonal returns chart - Yahoo Finance

    The article provides a seasonal returns chart for InnovAge Holding Corp. (INNV), displaying the average monthly price return from 2021 to 2026. It includes current stock information, after-hours trading...

    Yahoo Finance Singapore•11/3/26•Neutral

    InnovAge Holding Q1 2027 Earnings Call Transcript

    InnovAge Holding reported strong Q1 2027 financial results with revenue up 12.1% to $264.8 million and adjusted EBITDA growing over 75% to $31.3 million...

    Benzinga•11/3/26•Neutral

    Form 8K InnovAge Holding Corp For: 3 November By Investing.com

    InnovAge Holding Corp. filed a Form 8K for November 3rd, as reported by Investing.com. The article briefly mentions the filing and InnovAge's stock performance...

    Investing.com Nigeria•11/3/26•Neutral

    Profit rises 172.2% at InnovAge (INNV), which paid government settlements in October.

    InnovAge Holding Corp. (INNV) reported a significant increase in GAAP net income, rising 172.2% year-over-year to $20.9 million for the quarter ended September 30, 2026...

    Stock Titan•11/3/26•Somewhat-Bullish

    INNV Valuation and Fair Value

    P/E
    19.1x
    Forward P/E
    13.7x
    EV/EBITDA
    30.5x
    P/FCF
    16.0x
    PEG
    0.0x
    P/B
    4.8x
    See GNG's fair value

    INNV Profitability: Margins, ROIC and FCF

    Gross margin
    68.4%
    Operating margin
    7.6%
    Net margin
    0.9%
    ROIC
    5.0%
    ROE
    4.4%
    FCF margin
    7.5%
    FCF yield
    6.2%

    INNV Competitors

    CompanyTicker
    Tandem Diabetes Care IncTNDM
    Omeros CorporationOMER
    Artivion IncAORT
    Nektar TherapeuticsNKTR
    Mind Medicine IncMNMD
    Procept Biorobotics CorpPRCT
    Alpha Tau Medical LtdDRTS
    Tourmaline Bio Inc.TRML

    Sector: Healthcare

    INNV Analyst Ratings

    Consensus
    Hold
    Analysts
    3
    Strong Buy
    0
    Buy
    1
    Hold
    1
    Sell
    0
    Strong Sell
    1

    INNV Bull Case vs Bear Case

    Bull case

    • INNV beat EPS estimates in 87.5% of its last 8 reported quarters.
    • INNV grew quarterly revenue 12.1% year over year.

    Bear case

    • 33.3% of INNV's analyst ratings are Sell or Strong Sell.

    INNV Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    99.6%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $0.09
    Estimate revisions (30 days, fiscal period ending Dec 31, 2026)
    0 up, 0 down

    INNV Earnings Date

    INNV reports Feb 1, 2027. The date is estimated.

    INNV Earnings Call

    The latest INNV earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    INNV ETF Holders

    GNG tracks 7 ETFs that hold INNV. The largest weights:

    1. Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
    2. Dimensional U.S. Core Equity 2 ETF (DFAC), <0.01% of the fund
    3. iShares Russell 2000 ETF (IWM), <0.01% of the fund
    4. Schwab U.S. Broad Market ETF (SCHB), <0.01% of the fund
    5. Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
    Open the ETF Stock Exposure tool for INNV

    See insider activity

    Frequently Asked Questions About INNV

    When does INNV report earnings?

    InnovAge Holding Corp (INNV) is expected to report earnings on Feb 1, 2027.

    Does INNV pay dividends?

    InnovAge Holding Corp (INNV) does not currently pay a regular dividend.

    What is INNV's P/E ratio?

    InnovAge Holding Corp has a price-to-earnings (P/E) ratio of 19.09.

    What is INNV's market cap?

    InnovAge Holding Corp (INNV) has a market capitalization of $1.24B with a current stock price of $8.97.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In